Skip to Main Content
About
Pipeline
Platform
Investors
Careers
Our Team
Partnering
News & Events
Contact Us
ABCL635
ABCL575
Targets and Modalities
Publications
Current Openings
Partnering
News & Events
Contact Us
Clinical Trials
Publications
Current Openings
About
Our Team
Partnering
News & Events
Contact Us
Pipeline
ABCL635
ABCL575
Platform
Targets and Modalities
Publications
Investors
Careers
Current Openings
604.559.9005
Get in touch
News & events.
Our news.
Filter by Category
Filter by Category
News
Event
Text Link
Filter by Year
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Link 1
Filter by Category
News
Event
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
April 21, 2021
2021
AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
Read article
News
April 14, 2021
2021
AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration
Read article
News
April 12, 2021
2021
AbCellera to Present Virtually at Upcoming Investor Conferences
Read article
Event
April 7, 2021
2021
SynBioBeta Biopharma Day 2021
Read article
News
April 5, 2021
2021
Published Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19
Read article
News
April 1, 2021
2021
AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
Read article
Event
March 31, 2021
2021
US East Coast Antibody Therapeutics Xchange
Read article
Event
March 31, 2021
2021
Antibody Engineering & Therapeutics EU 2021
Read article
News
March 29, 2021
2021
AbCellera Reports Full Year 2020 Business Results
Read article
Event
March 11, 2021
2021
Biologics Europe: Online
Read article
1